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Abstract
Background: Pressure injuries (PIs) create a significant burden in the health care system. Up to 49% of critically ill
patients develop PIs. Identifying and understanding potential risk factors is essential to the provision of effective
targeted prevention strategies to mitigate risk. The objectives of this review are to identify patient-centred clinical
factors that may be associated with PI development in the adult intensive care environment and to determine the
effect size of the relationship between identified factors and PI development in this unique population.
Method/design: The review will follow the PRISMA reporting guidelines for systematic reviews. Electronic
databases (Cochrane; PubMed/MEDLINE; CINAHL (EBSCOhost); Embase; Scopus; PsycINFO; Proquest; Networked
Digital Library of Theses and Dissertations; Australian Digital Theses Program, Grey literature, Google scholar, and
Clinical Trial Registries) will be systematically searched. A suite of search terms will identify articles that have
examined the patient-centred risk factors for PI development in adult intensive care units. The search strategy will
be designed to retrieve studies published since inception to 2016 in English language. Quality of the studies will be
assessed by using an assessment framework designed to appraise quality in prognostic studies and methodological
considerations in the analysis and publication of observational studies. Screening, study selection process, and data
extraction will be undertaken by two independent reviewers. Disagreement will be resolved by discussion and, if
required, a third independent reviewer. Clinical and methodological heterogeneity across studies will be assessed
and, if possible, meta-analyses will be performed.
Discussion: The evidence synthesis arising from this review will identify person-centred risk factors that are
associated with PI development among critically ill patients in intensive care. Findings from this review will
demonstrate potential patient risk factors that may influence practice and research priorities to prevent PI
development and improve the quality of care provided.
Systematic review registration: PROSPERO CRD42016037690
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Pressure injuries (PIs) represent a common but poten-
tially preventable condition seen most often in high-risk
populations such as elderly persons, those with physical
impairments, and the critically ill [1–3]. Pressure
injuries, also known as pressure ulcers, are defined as a
damage or lesion to the skin and underlying soft tissue,
resulting from unrelieved pressure, shear, friction, mois-
ture, or a combination of these, usually over a bony
prominence or an anatomical area related to medical
devices [4]. Pressure injuries differ in size and in the
severity of affected tissue layers, with the latter ranging
from skin erythema to muscle and underlying bone
damage [4]. Moreover, PIs have significant negative
impacts related to patients, society, and health systems
(e.g. pain, increased infection rates, morbidity and
mortality, increased length of stay in hospital, and raised
financial costs) [5–7]. Preventing PI development to
reduce the burden of PIs for patients and health care
systems is considered a core aim of healthcare
organizations.
Evidence suggests that PIs can be prevented with the
implementation of PI prevention guidelines or care bun-
dles, which target known risk factors associated with PI
development [8–10]. Therefore, the identification and
understanding of risk factors is required in order to pro-
vide appropriate prevention interventions and better
utilize resources in practice.
Initial searching identified a systematic review pub-
lished on the risk factors associated with PI development
in adult hospitalized patients [11]. Findings identified
that the three main factors which contributed to PI
development were reduced mobility/activity, perfusion
alterations (e.g. diabetes, vascular disease, poor circula-
tion, blood pressure changes, smoking, oedema), and
skin or PI status (e.g. a history of a previous PI occur-
rence). Further, the review concluded that PI occur-
rences cannot be explained by a single factor. This
significant systematic review reported a total of 54 stud-
ies of which 13 studies were conducted in the intensive
care environment [11]. However, the review reported
only aggregate data from the 54 studies and no analyses
were reported on specific subpopulations such as critic-
ally ill intensive care unit (ICU) patients. In comparison
to general adult acute care in-patients, critically ill
patients are more susceptible to risk factors for PI devel-
opment as the majority of critically ill patients are venti-
lated and sedated and, therefore, unable to care for
themselves, move, or change position. Further, the
patient’s critical illness may involve hemodynamic
instability and oxygenation disorders, which potentially
may complicate and accelerate the effects of prolonged
immobility such as PI development. Extensive exposure
to pressure, from lying or sitting, on a specific part of
the body renders patients at greater risk of skin break-
down. The highest PI in-hospital prevalence and inci-
dence rates are noted in critically ill patients, thus
confirming that, when compared to the total hospital
population, the critically ill are at greatest risk for PI
development [12]. It is estimated that up to 40% of pa-
tients develop PIs during their admission to ICUs [13].
It has been argued that PI development is a complex
phenomenon that is enhanced by the presence of mul-
tiple, rather than single, risk factors in the individual
[14]. Two literature reviews have been retrieved that
have addressed the risk factors of PI development in the
intensive care context [15, 16]. Findings from the first
review [15] revealed that the potential risk factors for PI
development were the same among hospitalized patients,
despite critically ill patients having more than one factor.
These findings were supported with a second review
[16], which additionally explored different risk factors
that accelerate the development of PI in ICU contexts
and have an influence on the level and extent of tissue
necrosis. These factors were identified and conceptual-
ized in two categories: intrinsic (inherent factors of crit-
ical illness) and extrinsic (related to external forces)
factors. A total of 28 factors were identified as the main
risk factors for PI development in ICU settings in two or
more studies. The intrinsic factors identified in two or
more studies were older age, increased length of stay in
the ICU, and history of cardiovascular disease. The ex-
trinsic factors identified in two or more studies were the
administration of norepinephrine and patient reposi-
tioning (turning). However, these were literature reviews
[15, 16] in which no assessment of the methodological
quality of the studies reviewed was undertaken thus
making the interpretation of findings more susceptible
to bias. In addition, Coleman and colleagues [11] suggest
in their systematic review that multivariable statistical
modelling, the identification of potential factors associ-
ated with PI development, should be independent to
other risk factor variables included. An independent risk
factor does not infer causality. Rather, it is a risk factor
that ‘retains statistical association with the outcome
when other established risk factors are included in the
statistical model’ [17]. Thus, truly independent predict-
ive intrinsic, patient-centred risk factors for critically ill
patients in the ICU have yet to be conclusively
established.
A systematic review is required to synthesize compre-
hensive current evidence in order to identify potential
independent patient-centred clinical factors that are
associated with PI development among critically ill
patients in intensive care. Currently, after searching
across PubMed, CINAHL, the Cochrane Library, the
Joanna Briggs Institute Database of Systematic Reviews
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and Implementation Reports, and Google Scholar, no
current systematic review addressing risk factors of PIs
in this context has been identified. Identifying the poten-
tial independent person or patient-centred factors will
facilitate decision-makers such as researchers, clinicians,
and policy-makers to provide appropriate interventions
to alleviate the pressing problem of PI development.
Objectives
The objectives of this review are to (1) identify patient-
centred clinical factors that may be associated with PI
development in adult intensive care and (2) determine
the effect size of the association between identified
factors and PI development. The systematic review will
synthesize existing knowledge and make recommenda-
tions for future research.
Methods/design
This review will replicate the methodology used by Cole-
man and colleagues who identified PI risk factors in
adult hospitalized patients [11]. However, this review will
focus on adult intensive care patients.
This protocol adheres to the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses Protocol
(PRISMA-P) statement [18], and this is provided as an
Additional file 1. This review is registered with PROS-
PERO—registration number CRD42016037690.
Criteria for considering studies for this review
Types of studies
Eligible quantitative studies will be included in this re-
view. The systematic review will consist of studies using
either epidemiological designs such as retrospective or
prospective cohort studies, or experimental designs such
as randomized controlled trials or quasi-experimental
trials, where analyses for potential patient-centred clin-
ical factors of PI development in intensive care have
been reported. Cross-sectional, qualitative, case studies
and abstract-only reports, for which full text is not avail-
able, will be excluded from this review.
Type of clinical settings
Studies conducted in intensive/critical care settings will
be included.
Type of participants
This review will consider studies that included adult crit-
ically ill patients aged 18 or above, who have not been
diagnosed with a PI that developed before the patient
was admitted to the ICU.
Type of exposure
No restriction will be imposed for risk factors that are
significantly associated with PI development in intensive
care. Patient risk factors are defined as those factors
related to individual patient descriptors including age,
gender, diagnosis, comorbidities, body mass index, sever-
ity of illness, treatment modalities related to critical
illness, complications of treatment, clinical pathology,
length of ICU stay, and ICU outcome (discharge, trans-
fer, or death) [16]. In addition, studies that examine the
factors of PI development for adults across hospitals but
have separate statistical analyses reported for PI develop-
ment in adult intensive care will also be included.
Type of outcome measure
This review will consider studies that include all stages
of PI or equivalent as the outcome measure. According
to the National Pressure Ulcer Advisory Panel, European
Pressure Ulcer Advisory Panel, and Pan Pacific Pressure
Injury Alliance Clinical practice guidelines, the PI stages
reflect the level of skin tissue damage [4, 19].
Search methods of identification of studies
The search strategy aims to find both published and un-
published studies exploring the risk factors that are asso-
ciated with PI development in intensive care. The
literature will be searched using Medical Subject Head-
ings (MeSH) and combinations of key terms. The search
is limited to English language publications with no
restriction on the year of publication. The electronic
databases searches will include the Cochrane database
(1991 (established) to present); PubMed/MEDLINE
(1969–present); CINAHL (EBSCOhost) (1989 to
present); Embase (1966–present); Scopus (1975–
present); PsycINFO (2009 to present); Proquest (1959 to
present); and Google scholar. In addition, the reference
lists of articles meeting the criteria for this review will
be searched for further relevant studies. The search for
unpublished studies will include Networked Digital Li-
brary of Theses and Dissertations; Australian Digital
Theses Program; Open Grey (greynet.org); science.gov;
clinicaltrials.gov; International Standards for Rando-
mised Controlled Trials (IRSCTN) Registry; and the
Australian and New Zealand Clinical Trials Registry
(ANZCTR).
The search syntax will be designed and guided by the
Cochrane Handbook [20] to retrieve the relevant results.
Search strings will be focused on the terms pressure
ulcer, pressure injury, risk factors, predictors, adult
intensive care, and their synonyms.
Search terms
Medical Subject Headings (MeSH) and free text word
terms will be developed specifically for each database
and will be subsequently pilot tested. For example, for
MeSH, terms include (pressure ulcer* OR pressure injur*
OR bed sore* OR decubitus ulcer* OR pressure sore*)
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AND (risk factor* OR predictor* OR predictor factor*)
AND (intensive care* OR ICU OR critical care) AND
(adult OR age ≥18).
Data collection and analysis
Selection of studies
EndNote (Thomson Reuters) software will be used to
manage records for retrieval of articles and inclusion/ex-
clusion decisions. Two independent reviewers (both
authors) will perform the initial screening of titles and
abstracts to identify eligible studies (Additional file 2).
Full copies of all studies that meet the criteria as out-
lined below will be obtained for further assessment. The
inclusion criteria are (i) length of patient follow-up that
is at least 48 h (this has been identified as an accepted
time frame for PI development) [21], (ii) multivariate
analyses undertaken to identify factors affecting PI out-
come, and (iii) not specific to geographical areas. The
exclusion criteria are (i) observational studies that will
be excluded if >20% of the study sample were excluded
from analysis for reasons including withdrawal, death,
loss to follow-up, and missing records and (ii) control
trial studies will be excluded unless all of the following
minimum criteria are applied: parts of the study were
prospectively designed and intention to treat analyses
are reported [20].
Data extraction and management
Data will be extracted independently by the two
reviewers using the data extraction form. This form will
include the study characteristics (for example, study
population, recruitment type used, PI definition, and
analysis method) and risk factors investigated in the
multivariate models, including those found to be signifi-
cant. Non-significant factors through using a stepwise
regression will be included if it reported as independent
correlated variables to PI development. Disagreement
will be reconciled by discussion leading to mutual agree-
ment or, if this is not possible, consultation with a third
independent reviewer. In addition, authors will be
contacted if papers are unobtainable or the methods
reported need clarification.
Assessment of risk of bias in included studies
Both authors will undertake the risk of bias assessment
of the included studies independently, as guided by the
assessment framework for assessing quality in prognostic
studies and methodological considerations in the
analysis and publication of observational studies [11] as
described below.
Quality assessment
The methodological quality of eligible studies will be
assessed and critically appraised by two independent
reviewers (both authors) using the assessment framework
that is designed to appraise quality in prognostic studies
and methodological considerations in the analysis and
publication of observational studies [11]. Any disagree-
ments that arise between the reviewers will be resolved
through discussion or, if agreement is not reached, con-
sultation with a third, independent reviewer.
The quality assessment tool will rate the relevant
methodological parameters of studies across seven areas
[11]: selection bias (selection of target population),
confounders (whether confounders were controlled
using appropriate adjustment), data collection methods
(validity and reliability by using a clear definition or
description of the risk factor), reporting of continuous
variables (cut point), measurement of the range of po-
tential risk factors, withdrawals and dropouts (dropout
rates and completion of study rates), and no selective
reporting of results.
In addition, this tool has four considerations to
appraise domains quality:
1. Is there a sufficient number of events (rule of
thumb, 10 events per risk factor)?
2. Is there sufficient presentation of data to assess the
adequacy of method and analysis?
3. Is the strategy for model building (i.e. inclusion of
variables) appropriate and based upon a conceptual
framework?
4. Is the selected model adequate for the design?
Each criteria will be assessed as being met (yes/no/par-
tial/unsure). Consequently, assessment of domain criteria
will assist the determination of overall study quality [11].
Classification of study quality
The quality of the studies will be classified according to
the assessment framework for assessing quality and meth-
odological consideration in the analysis, meta-analysis,
and publication of observational studies [11] as high,
moderate, low, and very low quality based on the follow-
ing criteria:
High: yes for all four criteria
Moderate: yes for criteria 1 and at least 2 for other
criteria
Low: no for criteria 1 and no or partial for 2 other
criteria
Very low: no for criteria 1 and no or partial for all 3
other criteria
Unit/scale of analysis issues
The unit of analysis will be based on the individual
patient.
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Assessment of heterogeneity
The studies will be assessed by considering variability in
the clinical and methodological heterogeneity to ensure
sufficient homogeneity and rigour of the studies to con-
duct the meta-analysis procedure. Clinical heterogeneity
of the studies will be assessed by considering their popu-
lation, risk factor description, and outcome. Methodo-
logical heterogeneity will be assessed using the data
extracted on study design, procedure, and analysis
reported. In the absence of clinical and methodological
heterogeneity statistical measures, I2 and H2M statistic
measures [22, 23] will also be used to determine the
level of consistency between studies. I2 and H2M values
will be used to measure the impact of heterogeneity
between and within the study variance. An I2 ≥ 50%,
which corresponds to H2M > 0, will be considered a
significant level of heterogeneity.
Assessment of publication bias
The risk of publication bias will be minimized by compre-
hensively searching databases and obtaining data from un-
published work to reduce the risk of reporting bias [24,
25]. Moreover, if more than 10 studies are reviewed that
fit the criteria, a funnel plot will be used to determine the
relationship between study size and effect power of cohort
clinical trial studies by signs of asymmetry.
Data synthesis
A meta-analysis may not be able to be conducted due to
the clinical or statistical heterogeneity of the eligible
studies. However, if included studies are sufficiently
homogenous and rigorous, a meta-analysis using a
random-effects model will be conducted. A relative risk
will be the appropriate indicator of effect for potential
correlates in this review with a 95% confidence interval
(CI) calculated for binary outcomes (PI development).
However, if there is considerable clinical and design
heterogeneity in the included studies, the findings will
be presented in narrative form including tables to aid in
data presentation where appropriate.
Summary of findings
Patient-centred clinical risk factors for PI development
will be categorized by domains and subdomains accord-
ing to Coleman and colleagues [11]. Coding contributory
factors into different domains will be conducted by the
two authors independently. The identified domain and
sub-domain factor will be summarized and presented in
tables. Each sub-domain factor will be summarized
including a number of significant studies using a multi-
variable analysis and the total number and quality of the
studies entering the variable. Disagreements will be re-
solved by discussion to achieve consensus or, if this is
not possible, by a third independent reviewer.
Additional files
Additional file 1: PRISMA-P (Preferred Reporting Items for Systematic
Review and Meta-Analysis Protocols) 2015 checklist. (PDF 278 kb)
Additional file 2: Figure S1. Literature searches, screening and
selection of articles for inclusion. (PDF 102 kb)
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